» Articles » PMID: 35474295

Targeting NAD+: is It a Common Strategy to Delay Heart Aging?

Overview
Date 2022 Apr 27
PMID 35474295
Authors
Affiliations
Soon will be listed here.
Abstract

Heart aging is the main susceptible factor to coronary heart disease and significantly increases the risk of heart failure, especially when the aging heart is suffering from ischemia-reperfusion injury. Numerous studies with NAD+ supplementations have suggested its use in anti-aging treatment. However, systematic reviews regarding the overall role of NAD+ in cardiac aging are scarce. The relationship between NAD+ signaling and heart aging has yet to be clarified. This review comprehensively summarizes the current studies on the role of NAD+ signaling in delaying heart aging from the following aspects: the influence of NAD+ supplementations on the aging heart; the relationship and cross-talks between NAD+ signaling and other cardiac aging-related signaling pathways; Importantly, the therapeutic potential of targeting NAD+ in delaying heart aging will be discussed. In brief, NAD+ plays a vital role in delaying heart aging. However, the abnormalities such as altered glucose and lipid metabolism, oxidative stress, and calcium overload could also interfere with NAD+ function in the heart. Therefore, the specific physiopathology of the aging heart should be considered before applying NAD+ supplementations. We believe that this article will help augment our understanding of heart aging mechanisms. In the meantime, it provides invaluable insights into possible therapeutic strategies for preventing age-related heart diseases in clinical settings.

Citing Articles

Pleozymes: Pleiotropic Oxidized Carbon Nanozymes Enhance Cellular Metabolic Flexibility.

Vo A, Mouli K, Liopo A, Lorenzi P, Tan L, Wei B Nanomaterials (Basel). 2024; 14(24.

PMID: 39728553 PMC: 11728746. DOI: 10.3390/nano14242017.


Loss of cardiac mitochondrial complex I persulfidation impairs NAD homeostasis in aging.

Drekolia M, Karantanou C, Wittig I, Li Y, Fuhrmann D, Brune B Redox Biol. 2024; 69:103014.

PMID: 38171255 PMC: 10792955. DOI: 10.1016/j.redox.2023.103014.


Fingerstick blood assay maps real-world NAD disparity across gender and age.

Wang P, Chen M, Hou Y, Luan J, Liu R, Chen L Aging Cell. 2023; 22(10):e13965.

PMID: 37641521 PMC: 10577551. DOI: 10.1111/acel.13965.


Preclinical multi-target strategies for myocardial ischemia-reperfusion injury.

Li Y, Gao Y, Li G Front Cardiovasc Med. 2022; 9:967115.

PMID: 36072870 PMC: 9444048. DOI: 10.3389/fcvm.2022.967115.

References
1.
Zhang X, Williams E, Azhar G, Rogers S, Wei J . Does p49/STRAP, a SRF-binding protein (SRFBP1), modulate cardiac mitochondrial function in aging?. Exp Gerontol. 2016; 82:150-9. PMC: 4969173. DOI: 10.1016/j.exger.2016.06.008. View

2.
Azim N, Ahmad J, Iqbal N, Siddiqa A, Majid A, Ashraf J . Petri Net modelling approach for analysing the behaviour of [inline-formula removed] and signalling pathways in arrhythmogenic right ventricular cardiomyopathy. IET Syst Biol. 2021; 14(6):350-367. PMC: 8687399. DOI: 10.1049/iet-syb.2020.0038. View

3.
Ruan Y, Dong C, Patel J, Duan C, Wang X, Wu X . SIRT1 suppresses doxorubicin-induced cardiotoxicity by regulating the oxidative stress and p38MAPK pathways. Cell Physiol Biochem. 2015; 35(3):1116-24. DOI: 10.1159/000373937. View

4.
Chen L, Yang G . PPARs Integrate the Mammalian Clock and Energy Metabolism. PPAR Res. 2014; 2014:653017. PMC: 3945976. DOI: 10.1155/2014/653017. View

5.
Liu B, Ma R, Zhang J, Sun P, Yi R, Zhao X . Preventive Effect of Small-Leaved Kuding Tea ( (Roxb.) Bl.) Polyphenols on D-Galactose-Induced Oxidative Stress and Aging in Mice. Evid Based Complement Alternat Med. 2019; 2019:3152324. PMC: 6556317. DOI: 10.1155/2019/3152324. View